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ABStrAct
Interviews were conducted with 203 male and 95 female heroin injectors aged 17 to 25 in Dar 
es Salaam, Tanzania. Nearly one-quarter of participants reported injecting with needles used 
by someone else. Few reported cleaning needles with bleach. Multiple sexual partnerships, 
unprotected sex, and trading sex for money were especially present among women, the majority 
(55%) of whom was HIV seropositive. Self reports suggest the presence of heroin dependence 
among users. While most participants expressed a desire to quit their use, only 14 (5%) had been in 
treatment. There appears to be a large unmet need for heroin use treatment. These findings need to 
be considered in light of a potential forthcoming wave of heroin injection in sub-Saharan Africa.
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introDuction
Young injectors, under the age of 30, are at 
greater risk of HIV infection than older IDUs. 
Studies conducted in the United States and 
Canada show young injectors are more likely 
to share needles, drug paraphernalia, and in-
ject in groups more often than older injectors 
(Fennema, van Ameijden, van den Hoek, & 
Coutinho, 1997; Montgomery, Hyde, Derosa, 
Rohrbach, Ennett, Harvey et al., 2002; Morse, 
Morse, Burchfiel, & Zeanah, 1998; Fuller, Vla-
hov, Latkin, Ompad, Celentano, & Strathdee, 
2003; De, Cox, Boivin, Platt, & Jolly, 2007). 
The studies also found young injectors are 
more likely to be sexually active, have more 
sex partners, have sex more frequently and 
trade sex for money (Montgomery et al., 2002; 
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Fuller et al., 2003; Bacon, Lum, Hahn, Evans, 
Davidson, Moss et al., 2006; Gyarmathy & 
Neaigus, 2009; Rondinelli, Ouellet, Strathdee, 
Latka, Hudson, Hagan et al., 2009). While the 
reasons young IDUs are more likely to engage 
in some risk behaviors than older injectors are 
far from clear, they may stem from their youth 
and lack of experience. Young IDUs, new to 
injection drug use, are unlikely to be knowl-
edgeable about needle-sharing risks or possess 
the skills needed to negotiate and practice saf-
er injecting behaviours. Young injectors also 
lack the economic resources to provide a sta-
ble living environment, which may cause them 
to spend large amounts of time on the streets. 
Spending large amounts of time on the streets 
increases young IDUs’ chances of interacting 
with others engaging in risky needle use and 
sexual behaviours, including older adults more 
likely to be infected with HIV (Fuller et al., 
2003; Gyarmathy et al., 2009). 
Until recently, injection drug use was con-
sidered to be rare in sub-Saharan Africa; 
however studies suggest it is becoming more 
common (Ross, McCurdy, Kilonzo, Williams, 
& Leshabari, 2008; Parry, Dewing, Peterson, 
Carney, Needle, Kroeger et al., 2009). Studies 
of injectors in sub-Saharan Africa have shown 
rates of HIV risk behaviours among IDUs are 
high (Williams, McCurdy, Atkinson, Kilonzo, 
Leshabari, & Ross, 2007; Parry, Peterson, Car-
ney, Dewing, & Needle, 2008), as are rates of 
HIV infection (Williams, McCurdy, Bowen, 
Kilonzo, Atkinson, Ross et al., 2009). Newer 
high-risk injection practices, such as the use of 
“flashblood,” have also emerged. This practice 
consists of injecting blood drawn from a previ-
ous user (McCurdy, Ross, Williams, Kilonzo, 
& Leshabari, 2010). However, little research 
on injection drug use in sub-Saharan Africa 
extends beyond basic epidemiological studies. 
While these are important and necessary stud-
ies, it is also important to ascertain the prob-
lems IDUs associate with their drug use, their 
desire for help, and their past treatment expe-
riences. Studies conducted in the West have 
found many IDUs believe drug use causes 
severe problems in their lives and desire to 
stop using drugs, but that desire does not lead 
to entry into treatment programs or cessation 
of drug use on their own (Siegal, Falck, Wang, 
& Carlson, 2002; Wechsberg, Zule, Riehman, 
Luseno, & Lam, 2007). 
A large proportion of drug users in sub-Sa-
haran Africa may be 25 years of age or young-
er. This preliminary study presents results from 
a survey of risk behaviors, perceived problems 
of use, and treatment in a sample of. Unlike al-
most all other studies of IDUs in sub-Saharan 
Africa, data for this study are from a sample of 
heroin injectors aged 17 to 25.
MethoDS
Procedures 
Data for the study were collected between 
November 2009 and March 2010 in Dar es 
Salaam, Tanzania. Participants were recruited 
using aspects of targeted sampling, modified 
snowball sampling, and respondent driven 
sampling (Watters & Biernacki, 1989; Cun-
ningham-Williams, Cottler, Compton, Des-
mond, Wechsberg, Zule et al., 1999; Heck-
athorn, Semaan, Broadhead, & Hughes, 2002; 
Sadler, Lee, Lim, & Fullerton, 2010). To be-
gin sampling, six young IDUs eligible for the 
study were interviewed and asked to recruit 
others like themselves. Individuals referred to 
the study matching study criteria were inter-
viewed and asked to refer others. Participants 
were paid a small fee (3,000 Tanzanian. shil-
lings, about $1.50) for each person referred 
and interviewed. Referrals continued until the 
desired study size was reached. Participants 
were compensated (5,000 shillings, about 
$3.35) for their time and travel expenses for 
completing an interview.
Eligibility for the study was assessed by re-
sponses to a brief questionnaire. To be eligible 
for the study, individuals had to: (1) be 16 to 
25 years of age (16 and 17 year olds no longer 
living at home and considered emancipated 
in Tanzania were eligible); (2) have injected 
heroin at least once in the seven days before 
screening; (3) be able to show evidence of 
recent track marking; and (4) be willing to be 
tested for HIV infection. Eligible individuals 
3
HIV RISK IN TANZANIA
were given complete information about the 
study and asked to give informed consent. If 
consent was obtained, respondents were inter-
viewed by a trained research assistant. Inter-
views were conducted in a small rented office 
located in a neighborhood near the city center. 
The interview took 90 to 120 minutes. 
All procedures and data collection forms 
were reviewed and approved by university 
committees for the protection of human sub-
jects in Tanzania and the United States. In ad-
dition, procedures and forms were reviewed 
by the Tanzanian National Institute for Medi-
cal Research and the Tanzania Commission 
for Science and Technology.
Measures 
Data were collected using a computer as-
sisted, face-to-face survey. Measures were 
derived from surveys previously used with 
drug injectors in Dar es Salaam and the United 
States (Williams et al., 2007; Williams et al., 
2009; Williams, Ross, Atkinson, Bowen, Klov-
dahl, & Timpson, 2006). The same or similar 
measures to those used in this study produce 
reliable and valid data when used with drug 
users in non-institutional settings (Needle, 
Fisher, Weatherby, Brown, Cesari, Chitwood 
et al., 1995; Dowling-Guyer, Johnson, Fisher, 
Needle, Watters, Andersen et al., 1994; Darke, 
1998). 
The sociodemographic characteristics of 
participants which were measured included 
gender, age, religious preference (Muslim, 
Christian), education (years of schooling), 
self-perceive homelessness, self-perceived 
sexual orientation (heterosexual, bisexual, ho-
mosexual), and marital status (single, married 
or living with a partner of the opposite sex, 
living with a partner of the same sex). Partici-
pants’ economic circumstances were assessed 
by income and the number of days worked in 
the 30 days before they were interviewed. 
Injection drug use was measured by asking 
participants how often they had injected in the 
previous 30 days and whether they had inject-
ed with needles previously used by someone 
else and the number of times they had used 
bleach to clean a needle. Participants were also 
asked the number of times they had injected 
flashblood in the previous seven days. Sexual 
behaviors in the last 30 days were assessed by 
asking participants how many times they had 
engaged in oral, anal, and vaginal sex. The to-
tal number of sex partners (of any type) was 
ascertained. Sexually active participants were 
asked how many times a condom was used. 
Participants were deemed to have consistently 
used condoms if the number of times used 
condoms equaled the number of times had 
sex. Sexual risk was also measured by asking 
participants how many times in the previous 
30 days they had traded sex for money and sex 
for drugs. 
HIV status was established using the Capil-
lus (Trinity Biotech, Bray, Ireland) and the De-
termine (Abbot Japan Co. Ltd, Tokyo, Japan) 
tests. Quality control was performed by the Af-
rican Medical Research and Education Foun-
dation reference laboratory in Dar es Salaam.
Problems related to participants’ drug use 
were assessed by asking them to respond “no” 
or “yes” to the following questions. “Do you 
neglect other pleasures or interests in favor of 
using heroin?” “Are you interested in quitting 
drug use?” “Do you have a strong desire or 
sense of compulsion to use heroin?” “Do you 
find it difficult or impossible to control your 
use of heroin?” “Do you experience with-
drawal symptoms after going without heroin 
for a while?” “Do you use heroin to relieve or 
avoid withdrawal symptoms?” “Do you notice 
that you required more heroin to achieve the 
same physical or mental effects?” “Do you ex-
perience psychological or physical harm from 
heroin?” 
Participants were also asked, “Do you want 
to stop using drugs?” “Have you ever tried to 
quit using drugs on your own?” Those stating 
they had tried to quit were then asked, “How 
long were you able to quit using drugs?” Re-
sponses were recorded in weeks. Additionally, 
participants were asked, “Have you ever been 
in drug treatment?” Those responding “yes” 
were then asked what kind of treatment they 
had been in. Lastly, participants were asked 




Differences in these variables by gender 
were assessed with independent-samples 
t-tests (with equal variances assumed) and chi-
square tests as appropriate. The level of sig-
nificance was p < .05, 2-tailed.
reSultS
Sample characteristics 
A total of 298 interviews were avail-
able for analysis. The sample consisted of 
203 males (68%) and 95 females (32%). 
In accordance with eligibility criteria, par-
ticipants’ ages ranged from 17 to 25 with 
a mean age of 23.2 (sd = 2.0). Participants 
had a mean of 6.3 years of schooling (sd = 
2.6). A total of 203 participants (68%) were 
Muslim and 95 (32%) were Christian. Par-
ticipants had worked an average of 15.9 (sd 
= 14.4) days in the 30 days prior to their 
interview and had a mean income in that 
time of 235,823.05 shillings (approximate-
ly $160) (sd = 122,615.50, approximately 
$80). There were 109 participants (37%) 
who considered themselves homeless. All 
males and 94 females (99%) described 
themselves as heterosexual. One female 
(1%) described herself as bisexual. Of the 
males, 194 (96%) were single and 9 (4%) 
were married or living with a partner of the 
opposite sex. Of the females, 81 (85%) were 
single and 14 (15%) were married or living 
with a partner of the opposite sex (χ2 = 9.65; 
df = 1; p < .002). 
injection Behaviors 
Participants had injected heroin on average 
88.4 (sd = 18.9) times in the prior 30 days. 
Sixty-six participants (22%) had injected in 
the previous 30 days with needles which had 
been used by someone else. Three males (1%) 
and no females had used bleach at least once 
to clean their needles in the previous 30 days. 
One male (< 1%) and one female (1%) had 
injected with flashblood in the previous seven 
days. These injection behaviours did not differ 
by gender. 
Sexual Behaviors
Overall, 106 males (52%) and 88 females 
(93%) had at least one sex partner in the previ-
ous 30 days (χ2 = 46.53; df = 1; p < .001). Sex-
ually active males had a mean of 1.7 partners 
(SD = 1.0) and females had a mean of 54.6 
(sd = 73.6) partners (t = -7.40; df = 192; p < 
.001). Forty-three males (21%) had more than 
one partner compared to 77 females (81%) (χ2 
= 96.44; df = 1; p < .001). Four males (2%) 
and 17 females (18%) had engaged in anal sex 
in the 30 days preceding their interview (χ2 = 
25.05; df = 1; p < .001). Eight males (4%) and 
10 females (11%) had engaged in oral sex (χ2 = 
4.95; df = 1; p = .03). One-hundred-five males 
(52%) and 88 females (93%) reported vaginal 
sex (χ2 = 47.46; df = 1; p < .001). Males re-
ported having vaginal sex an average of 2.9 
times (sd = 2.0) while females had sex 87.5 
times on average (SD = 95.1) (t = -9.11; df = 
191; p < .001). 
Four males (2%) had traded sex for money 
in the previous 30 days compared to 78 (82%) 
of the females (χ2 = 208.36; df = 1; p < .001). 
Three males (2%) had traded sex for drugs as 
had 16 females (17%) (χ2 = 25.59; df = 1; p 
< .001). No males and 1 female (10%) stated 
they had used condoms every time they had 
oral sex in the previous 30 days, with data 
missing for one male. Gender differences for 
condom use for oral and anal sex were not sig-
nificant. No males and 5 females (29%) had 
consistently used condoms for anal sex. Six-
teen males (15%) and 24 females (27%) stated 
they had used condoms every time they had 
vaginal sex (χ2 = 4.09; df = 1; p = .04), with 
data missing for one male. 
hiV Serostatus
Forty-one males (20%) and 52 females (55%) 
had previously been tested for HIV (χ2 = 35.96; 
df = 1; p < .001). Of these, 36 males (88%) and 
50 females (96%) had gotten their test results, 
a nonsignificant difference. Of these, one male 
(3%) and five females (10%) reported they had 
tested positive; reported serostatus did not vary 
by gender. For this study, HIV test results were 
available for 198 males (98%) and 91 females 
(96%). Among these participants, 24 males 
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(12%) and 50 females (55%) were seropositive 
(χ2 = 60.02; df = 1; p < .001). 
Drug use Severity and treatment 
Table 1 shows the number and percentage 
of respondents answering in the affirmative to 
the substance use severity and treatment ques-
tions. As seen, substantial majorities endorsed 
the severity items and had a desire to quit. 
With regard to ceasing drug use, approxi-
mately one-fifth of participants had tried to 
quit on their own. Of the 63 participants who 
had tried to quit using drugs on their own, the 
mean length of time they had been able to quit 
was 22.2 (SD = 36.5) weeks. Of the 14 par-
ticipants who had been in drug treatment, five 
had been in day treatment; four had been in in-
patient rehabilitation; three had been in outpa-
tient treatment; and two had been in in-patient 
detoxification. One male stated knowing what 
methadone and buprenorphine treatment were. 
Responses to the severity and treatment items 
did not vary by gender.
DiScuSSion 
Injection heroin use is an increasingly im-
portant risk factor for the transmission of HIV 
in sub-Saharan Africa. In addition to being a 
risk factor for HIV transmission, use may re-
sult in lost opportunity and decreased produc-
tivity. Users are engaging in an illegal activity 
and may turn to other illegal activities such as 
exchanging sex for money or drugs which car-
ry their own risk of transmission. These risks 
may be especially prevalent among young 
injectors. Users are often those who are mar-
ginalized in terms of resources or status, and 
those who are HIV seropositive may perceive 
additional stigmatization. Cases resulting 
from injection drug use may present increas-
ing demands on treatment systems. However, 
it may also be early enough in the injection 
epidemic that effective plans can be developed 
and implemented. Part of this process will be 
understanding users’ perception of the sever-
ity of their drug use problems as well as their 
treatment needs and experiences. 
Results of our surveys conducted with 
young injectors show marginalization as re-
flected in the mean levels of education and in-
come and in the proportion of participants who 
thought of themselves as homeless. As noted, 
such marginalization may lead to exposure to 
riskier drug use and sexual settings. On aver-
age, participants were injecting three times 
a day, one-fifth had injected with previously 
table 1: Addiction Severity and Treatment Experience (N = 298)
N %
Do you neglect other pleasures or interests in favor of using heroin? 280 94%
Are you interested in quitting drug use? 295 99%
Do you have a strong desire or sense of compulsion to use heroin? 291 98%
Do you find it difficult or impossible to control your use of heroin? 261 90%
Do you experience withdrawal symptoms after going without heroin for a while? 286 96%
Do you use heroin to relieve or avoid withdrawal symptoms? 289 97%
Do you notice that you required more heroin to achieve the same physical or mental effects? 283 95%
Do you experience psychological or physical harm from heroin? 289 97%
Do you want help to stop using drugs? 296 99%
Have you ever tried to quit using drugs on your own? 63 21%
Have you ever been in drug treatment? 14 5%
Do you know what methadone treatment is? 1 < 1%
Do you know what buprenorphine treatment is? 1 < 1%
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used needles, and few had used bleach to clean 
their needles. However, in this sample, injec-
tors were not engaged in using flashblood. 
Among women, an interaction of injection 
drug use and sex was present. The majority of 
women in this sample was sexually active, had 
multiple partners, and had recently traded sex 
for money. Most had engaged in unprotected 
sex. The majority of women were HIV sero-
positive, and many infected participants do not 
appear to have been previously aware of their 
serostatus. Also of note is the percentage of 
males who were sexually inactive. While drug 
use may often decrease inhibitions, heroin use 
may also suppress libido.
The findings of this study regarding gender 
and sexual behavior support those of Williams 
et al. (2007). A greater proportion of women 
than men in Dar es Salaam were then found to 
be sexually active. Women were more likely to 
have traded sex for money or drugs, engaged 
in vaginal sex more frequently and had more 
partners. As in the current study, many males 
were sexually inactive. Unlike the present 
study, men were more likely to have injected 
with used needles. 
Responses to the severity and treatment 
items show participants perceived serious 
problems related to their drug use. These were 
manifested in terms of a compulsion to use 
heroin and an inability to control usage. Par-
ticipants reported needing to use more of the 
drug to maintain effects and withdrawal when 
usage stopped. Participants experienced physi-
cal and psychological problems resulting from 
use and expressed a desire for help in quitting. 
Despite this desire, relatively few had tried 
to quit on their own. Among those trying, the 
average participant was able to quit for about 
four months. Fewer participants had actually 
been in treatment. Results also showed a lack 
of knowledge of pharmacological treatments. 
While not diagnostic, the findings suggest a 
level of problems indicative of substance de-
pendence. 
There were limitations to this study. The 
sample of injection drug users was not selected 
randomly. However, this is true of most stud-
ies involving drug users as random sampling 
techniques often do not apply to such a hid-
den population. The study was conducted in 
one city among a sample of young adult heroin 
users which was predominantly heterosexual, 
and thus the generalizability of the findings 
to other settings and individuals may be lim-
ited. Measures of drug use and sexual behav-
iors were based on self-report. However, as 
noted, such measures have been found to be 
valid and reliable in previous studies of drug 
users (Needle, Fisher, Weatherby, Brown, Ce-
sari, Chitwood et al., 1995; Dowling-Guyer, 
Johnson, Fisher, Needle, Watters, Andersen et 
al., 1994; Darke, 1998). Due to the maximum 
age requirement for eligibility, it is suspected 
that some participants over the age of 25 may 
have lied about their age. Measures of sever-
ity consisted of dichotomous response items 
and were not intended as clinical assessments. 
With regard to participants who reported pre-
vious treatment, it was not known whether 
these individuals completed treatment or how 
long they were able to maintain abstinence fol-
lowing treatment. Barriers to treatment were 
not assessed. Nor did this study consider psy-
chological factors such as depression which 
may affect risk taking. While participants 
were shown to be marginalized, stigma related 
to drug use, sexual behavior, or HIV infection 
was not assessed. 
A strength of this study is that it was con-
ducted with a sample of young injectors. Re-
sponses to the study items indicate that par-
ticipants perceived serious problems related to 
their use, want to quit drug use, and desire help 
in quitting. Results show the need for increas-
ing injectors’ awareness of the risks related to 
needle use and sex. As detailed by McCurdy 
et al., government sponsored harm reduction 
efforts include outreach; information and com-
munication; risk reduction counseling; HIV 
testing and counseling; and detoxification pro-
grams. In 2005, over 200,000 previously un-
tested individuals sought VCT services. Over 
100,000 HIV patients were enrolled in care 
and treatment sites at the end of 2006 (Mc-
Curdy et al., 2010). 
There may be limits to a harm reduction 
approach with injectors. As noted, there are 
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currently no needle exchange or opiate substi-
tution programs in Tanzania, and awareness of 
methadone and buprenorphine was virtually 
nonexistent. Heroin injection is an illegal ac-
tivity. Providers may not want to appear to be 
condoning such behaviour. Efforts to address 
this concern and pilot studies to assess the 
feasibility and effectiveness of such programs 
might be called for. The fact that participants 
expressed a desire to quit drug use suggests 
users may be amenable to abstinence based in-
terventions. On the other hand, with regard to 
sexual behaviors, it may be unrealistic to expect 
sexual abstinence among young adults. Harm 
reduction measures which emphasize consis-
tent condom use and monogamous relation-
ships may be appropriate (Hilton, Thompson, 
Moore-Dempsey, & Janzen, 2001). Bowser 
and colleagues found a California based harm 
reduction focused drug treatment program for 
female users engaged in trading to be an ef-
fective preparation for achieving full recovery 
(Bowser, Ryan, Smith, & Lockett, 2008). 
Given these efforts to reduce risks and to im-
prove testing and treatment services, consider-
ations to address remain. Stigma is associated 
with drug use, HIV, and prostitution which 
may prevent injectors from seeking services. 
While services are becoming more available, 
users may not have knowledge of, or access, 
to them. Some users may not believe in the 
efficacy of treatment. Services will be limited 
by the resources and technologies available to 
providers. There may be a need for collabo-
ration among the different actors involved in 
HIV and drug use prevention and treatment. 
For example, Rothman et al. considered the 
“co-location” of HIV prevention and primary 
care services within drug treatment programs 
in New York State (Rothman, Rudnick, Slifer, 
Agins, Heiner, & Birkhead, 2007). The extent 
to which programs such a those described by 
Bowser and Rothman can be feasible in other 
settings needs to be evaluated.
Several additional avenues for future re-
search and intervention are suggested. These 
include administering diagnostic measures of 
drug use severity in order to address the ques-
tion of how self-reported responses would 
compare to diagnostic criteria of substance 
abuse or dependence. Studies should include 
the use of theoretical models of behaviour 
such as Fishbein’s Integrative Model to exam-
ine injectors’ intention to enter treatment and 
subsequent treatment behavior as a function 
of attitudes, self-efficacy, and norms regard-
ing entering treatment (Fishbein, 2008). Such 
a model could be applied to other relevant 
behaviors such as safe injection practices and 
condom use. A stages of change model may 
be useful in distinguishing those who have ac-
tually entered treatment from those who have 
not. Injectors should be asked about barriers 
they face to entering treatment or trying to quit 
on their own. The present findings will be en-
hanced by analysis of qualitative interviews 
conducted in the summer of 2010. 
Many infected participants were not aware 
of their positive serostatus before being tested 
for this study or, alternatively, may not have 
wanted to disclose their status. Efforts appear 
warranted to help women transition from sur-
vival sex. Several males reported no recent 
sexual activity. While this may be desirable 
from a disease transmission perspective, it 
may be less so from a quality of life one since, 
as noted, heroin has been associated with de-
creased libido. Efforts to address these issues 
may be warranted. Injectors may be aided by 
interventions such as twelve-step programs 
and other group therapy approaches as pre-
sented by Flores (1997). 
Injection drug use appears poised to chal-
lenge the healthcare and drug treatment ser-
vices of sub-Saharan Africa. At the same time, 
an understanding of injectors’ risk behaviors, 
their perceptions about drug use and drug 
treatment would make a contribution to devel-
oping workable public health solutions to the 
emerging epidemic.
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